Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

24 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Impact of Etiological Cytogenetic Abnormalities on the Depth of Immunoparesis and Survival in Newly Diagnosed Multiple Myeloma.
Caro J, Cairns D, Menzies T, Boyle E, Pawlyn C, Cook G, Kaiser M, Walker BA, Owen R, Jackson GH, Morgan GJ, Heaney J, Drayson MT, Davies FE. Caro J, et al. Among authors: menzies t. Clin Lymphoma Myeloma Leuk. 2022 Apr;22(4):e279-e284. doi: 10.1016/j.clml.2021.10.008. Epub 2021 Oct 18. Clin Lymphoma Myeloma Leuk. 2022. PMID: 34876373
Autologous stem cell transplantation is safe and effective for fit older myeloma patients: exploratory results from the Myeloma XI trial.
Pawlyn C, Cairns D, Menzies T, Jones J, Jenner M, Cook G, Boyd K, Drayson M, Kaiser M, Owen R, Gregory W, Morgan G, Jackson G, Davies F. Pawlyn C, et al. Among authors: menzies t. Haematologica. 2022 Jan 1;107(1):231-242. doi: 10.3324/haematol.2020.262360. Haematologica. 2022. PMID: 33297668 Free PMC article. Clinical Trial.
Sex Differences in Multiple Myeloma Biology but not Clinical Outcomes: Results from 3894 Patients in the Myeloma XI Trial.
Bird S, Cairns D, Menzies T, Boyd K, Davies F, Cook G, Drayson M, Gregory W, Jenner M, Jones J, Kaiser M, Owen R, Jackson G, Morgan G, Pawlyn C. Bird S, et al. Among authors: menzies t. Clin Lymphoma Myeloma Leuk. 2021 Oct;21(10):667-675. doi: 10.1016/j.clml.2021.04.013. Epub 2021 Apr 24. Clin Lymphoma Myeloma Leuk. 2021. PMID: 34059488 Free PMC article. Clinical Trial.
Minimal Residual Disease After Autologous Stem-Cell Transplant for Patients With Myeloma: Prognostic Significance and the Impact of Lenalidomide Maintenance and Molecular Risk.
de Tute RM, Pawlyn C, Cairns DA, Davies FE, Menzies T, Rawstron A, Jones JR, Hockaday A, Henderson R, Cook G, Drayson MT, Jenner MW, Kaiser MF, Gregory WM, Morgan GJ, Jackson GH, Owen RG. de Tute RM, et al. Among authors: menzies t. J Clin Oncol. 2022 Sep 1;40(25):2889-2900. doi: 10.1200/JCO.21.02228. Epub 2022 Apr 4. J Clin Oncol. 2022. PMID: 35377708
The addition of vorinostat to lenalidomide maintenance for patients with newly diagnosed multiple myeloma of all ages: results from 'Myeloma XI', a multicentre, open-label, randomised, phase III trial.
Jenner MW, Pawlyn C, Davies FE, Menzies T, Hockaday A, Olivier C, Jones JR, Karunanithi K, Lindsay J, Kishore B, Cook G, Drayson MT, Kaiser MF, Owen RG, Gregory W, Cairns DA, Morgan GJ, Jackson GH; UK National Cancer Research Institute (NCRI) Haemato-oncology Clinical Studies Group. Jenner MW, et al. Among authors: menzies t. Br J Haematol. 2023 Apr;201(2):267-279. doi: 10.1111/bjh.18600. Epub 2022 Dec 21. Br J Haematol. 2023. PMID: 36541152 Free PMC article. Clinical Trial.
Maintenance lenalidomide in newly diagnosed transplant eligible and non-eligible myeloma patients; profiling second primary malignancies in 4358 patients treated in the Myeloma XI Trial.
Jones JR, Cairns DA, Menzies T, Pawlyn C, Davies FE, Sigsworth R, Brioli A, Jenner MW, Kaiser MF, Olivier C, Reed M, Drayson MT, Owen RG, Boyd KD, Cook G, Morgan GJ, Jackson GH; NCRI Haemato-Oncology CSG. Jones JR, et al. Among authors: menzies t. EClinicalMedicine. 2023 Jul 27;62:102099. doi: 10.1016/j.eclinm.2023.102099. eCollection 2023 Aug. EClinicalMedicine. 2023. PMID: 37554123 Free PMC article.
Progression free survival of myeloma patients who become IFE-negative correlates with the detection of residual monoclonal free light chain (FLC) by mass spectrometry.
Giles HV, Drayson MT, Kishore B, Pawlyn C, Kaiser M, Cook G, de Tute R, Owen RG, Cairns D, Menzies T, Davies FE, Morgan GJ, Pratt G, Jackson GH. Giles HV, et al. Among authors: menzies t. Blood Cancer J. 2024 Mar 18;14(1):50. doi: 10.1038/s41408-024-00995-y. Blood Cancer J. 2024. PMID: 38499538 Free PMC article.
Resistance of New Zealand Provenance Leptospermum scoparium, Kunzea robusta, Kunzea linearis, and Metrosideros excelsa to Austropuccinia psidii.
Smith GR, Ganley BJ, Chagné D, Nadarajan J, Pathirana RN, Ryan J, Arnst EA, Sutherland R, Soewarto J, Houliston G, Marsh AT, Koot E, Carnegie AJ, Menzies T, Lee DJ, Shuey LS, Pegg GS. Smith GR, et al. Among authors: menzies t. Plant Dis. 2020 Jun;104(6):1771-1780. doi: 10.1094/PDIS-11-19-2302-RE. Epub 2020 Apr 9. Plant Dis. 2020. PMID: 32272027 Free article.
24 results